- Home
- KORE vs ALGS Comparison
KORE vs ALGS Comparison
Compare KORE & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- ALGS
- Stock Information
- Founded
- KORE 2003
- ALGS 2018
- Country
- KORE United States
- ALGS United States
- Employees
- KORE N/A
- ALGS N/A
- Industry
- KORE Telecommunications Equipment
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- KORE Consumer Discretionary
- ALGS Health Care
- Exchange
- KORE Nasdaq
- ALGS Nasdaq
- Market Cap
- KORE 44.4M
- ALGS 38.8M
- IPO Year
- KORE N/A
- ALGS 2020
- Fundamental
- Price
- KORE $2.55
- ALGS $7.14
- Analyst Decision
- KORE Buy
- ALGS Strong Buy
- Analyst Count
- KORE 2
- ALGS 1
- Target Price
- KORE $10.00
- ALGS $70.00
- AVG Volume (30 Days)
- KORE 9.8K
- ALGS 140.5K
- Earning Date
- KORE 05-14-2025
- ALGS 03-10-2025
- Dividend Yield
- KORE N/A
- ALGS N/A
- EPS Growth
- KORE N/A
- ALGS N/A
- EPS
- KORE N/A
- ALGS N/A
- Revenue
- KORE $285,229,000.00
- ALGS $3,945,000.00
- Revenue This Year
- KORE $3.89
- ALGS $580.86
- Revenue Next Year
- KORE $5.35
- ALGS N/A
- P/E Ratio
- KORE N/A
- ALGS N/A
- Revenue Growth
- KORE 7.01
- ALGS N/A
- 52 Week Low
- KORE $1.10
- ALGS $6.76
- 52 Week High
- KORE $4.88
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- KORE 54.75
- ALGS 24.28
- Support Level
- KORE $2.41
- ALGS $10.45
- Resistance Level
- KORE $2.60
- ALGS $9.76
- Average True Range (ATR)
- KORE 0.16
- ALGS 1.11
- MACD
- KORE -0.01
- ALGS 0.15
- Stochastic Oscillator
- KORE 81.82
- ALGS 2.13
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.